Atlas Trials

RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer

Clinical trial NCT05966194 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05966194
Sponsor
EpicentRx, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Oral Mucositis
Start date
2024-04-02
Primary completion
2027-07-01
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.